Cyprus Mail

Isis Pharma changes “unfortunate” name to avoid confusion

After deliberating for most of the year, Isis Pharmaceuticals Inc said on Friday it would change its name to avoid being confused with the Islamist militant group known as ISIS.

The biotechnology company said it would be called Ionis Pharmaceuticals Inc from Dec. 22 and also changed its stock exchange ticker symbol to “IONS” from “ISIS”.

“It’s been an ongoing discussion for most of this year”, Chief Business Officer Sarah Boyce told Reuters.

“When you talk about the company you want people to immediately think about the incredible work you’re doing to deliver transformational drugs to patients … not as an unfortunate namesake.”

The Carlsbad, California-based company’s stock dropped about 4 percent on the first trading day after the Paris attacks, for which ISIS claimed responsibility.

The drugmaker – named after the Egyptian protector and healer goddess Isis, who was revered as a protector and healer – has been around for more than a quarter century.

Today it is a $7 billion company with one cholesterol drug on the market and treatments in development for a plethora of diseases, including cancer and heart conditions.


Related posts

Paris prosecutor opens inquiry into whether Epstein committed crimes in France

Reuters News Service

France’s Macron to push for charter on biodiversity at G7 summit

Reuters News Service

As Amazon fires rage, Brazil tells diplomats to fix image

Reuters News Service

EU piles pressure on Brazil over Amazon fires

Reuters News Service

Billionaire industrialist and conservative donor David Koch dies at age 79

Reuters News Service

Russia rocket accident likely had two explosions, Norway monitor says

Reuters News Service

1 comment

Comments are closed.